Abstract
Marginal bone loss (MBL) is one of the leading causes of dental implant failure. This study aimed to investigate the feasibility of machine learning (ML) algorithms based on trabeculae microstructure parameters to predict the occurrence of severe MBL. Eighty-one patients (41 severe MBL cases and 40 normal controls) were involved in the current study. Four ML models, including support vector machine (SVM), artificial neural network (ANN), logistic regression (LR), and random forest (RF), were employed to predict severe MBL. The area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, and specificity were used to evaluate the performance of these models. At the early stage of functional loading, severe MBL cases showed a significant increase of structure model index and trabecular pattern factor in peri-implant alveolar bone. The SVM model exhibited the best outcome in predicting MBL (AUC = 0.967, sensitivity = 91.67%, specificity=100.00%), followed by ANN (AUC = 0.928, sensitivity = 91.67%, specificity=93.33%), LR (AUC = 0.906, sensitivity = 91.67%, specificity = 93.33%), RF (AUC = 0.842, sensitivity = 75.00%, specificity = 86.67%). Together, ML algorithms based on the morphological variation of trabecular bone can be used to predict severe MBL.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Natural Science Foundation of China Grant (81771092), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 2018-87), and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX19_1149).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
the ethics committee of the Affiliated Stomatological Hospital of Nanjing Medical University (Approval number: PJ2019-038-001, Approval data: March 15, 2019)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All CBCT files of patients and control subjects were stored in a non-public medical record database. CBCT data of the samples will not be shared.
